
Surgical Robot Developer
September 7, Tuodao Medical's Tuoshu®Percutaneous Puncture Surgical Robot (i.e., NP100 Puncture Surgery Navigation and Positioning System) Officially Approved for Market Launch!
Percutaneous biopsy is a critical method for the surgical diagnosis of tumors. Traditional freehand biopsy techniques demand extensive clinical experience from physicians. However, precision can be compromised by patient respiration and tissue shift, potentially leading to inaccurate needle placement and even complications. With technological advancements, surgical robots have been increasingly employed to assist in percutaneous biopsy procedures, effectively mitigating clinical risks.Percutaneous Puncture Surgical Navigation and Positioning Is Emerging as a Key Exploration Direction in the Global Smart Healthcare Industry, with Vast Market Prospects.
Tuodao Medical has been deeply engaged in the smart healthcare industry for many years, accumulating extensive expertise in artificial intelligence technologies such as image analysis and tracking localization. Tuoshu®The official launch of the percutaneous puncture surgical robot signifies a major breakthrough for Tuodao Medical in this new sector, providing the healthcare industry with morePrecision, Efficiency, Safetysurgical navigation and positioning solutions, making significant contributions to the advancement of the smart healthcare industry.

Tuoshu® Percutaneous Puncture Surgical Robot (*National Medical Device Registration No. 20233011291)

Overall Scenario
Tuodao Technology®The percutaneous puncture surgical robot consists of a robotic arm cart, an optical tracking system cart, a patient tracker, and a navigation and positioning toolkit.



Details Display
After acquiring medical images of the patient’s lesion via CT scanning, the physician transmits the data to the system for needle insertion planning, which includes information such as the entry point, angle, and depth, thereby completing the overall surgical plan. Once the planned trajectory is confirmed, the robotic arm automatically tracks to the corresponding position, providing a stable end-effector holding platform. During the procedure, the robotic arm achieves precise positioning based on the physician’s plan to assist in the surgery.
Meanwhile, Tuodao’s independently developed optical-pressure dual-source real-time tracking technology enables real-time monitoring of patient position and respiratory phase changes, ensuring surgical safety and improving needle placement accuracy.

Detail Display
About Tuodao Medical
Tuodao Medical is committed to providing robotic solutions for medical users across all departments, empowering the development of the smart healthcare industry through technological innovation.
Leveraging cutting-edge core technologies such as data algorithms, artificial intelligence, and precision intelligent control, Tuodao Medical has meticulously developed a core technological platform for surgical robots. The company has strategically laid out its presence in five key sectors related to surgical robotics: orthopedic surgical robots, laparoscopic surgical robots, needle-guided surgical robots, natural orifice transluminal endoscopic surgery (NOTES) robots, and medical imaging equipment. By deeply cultivating diverse clinical departments and surgical applications, Tuodao Medical’s product pipeline now covers orthopedics, general surgery, gynecology, urology, pulmonology, radiology, and other specialties.
In the future, upholding its corporate mission of “Making Surgery Simpler, Making Life Healthier,” Tuodao Medical will collaborate with industry and ecosystem partners to achieve a comprehensive product portfolio layout, build an integrated remote smart healthcare center, and jointly shape the future of human health.
In 2022, Tuodao Medical’s Tuoshou Orthopedic Surgical Robot and Daoying Mobile C-arm X-ray Machine were approved for market launch; in 2023, the Daoying 3D Mobile C-arm X-ray Machine and Tuoying®Mobile C-arm X-ray Machine, Tuodao®Percutaneous Puncture Surgical Robot Obtains Certification and Achieves Commercialization.